Skip to main content
. Author manuscript; available in PMC: 2023 Sep 6.
Published in final edited form as: Clin Ther. 2019 Oct 22;41(10):1939–1954.e1. doi: 10.1016/j.clinthera.2019.08.011

Table II.

Risk factors for disseminated coccidioidomycosis.1,6,10,12,20,34,35,5557

Older Age Primary Immunodeficiency
Male Gender  Hyper IgE syndrome (STAT3 mutations)
Pregnancy  IFN-γR1 polymorphisms
Black race and Filipino ancestry  IL12-Rβ1 or IL12-Rβ2 mutations
 STAT1 gain of function polymorphisms
Immunosuppression Other suspected deleterious genetic lesions
 HIV  Innate immune sensing*
 Cancer/Chemotherapy  Signaling from innate sensing*
 Solid Organ Transplantation  NFkB signaling*
 Anti-inflammatory biological medications  IL-17 signaling*,**
 Human chitinase (CHIT1)**
*

Reference Hardison and Brown.36

**

This report.